Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
about
An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.Activation of antigen-presenting cells by DNA delivery vectors.Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.The search for animal models for Lassa fever vaccine developmentVaccine Platforms to Control Arenaviral Hemorrhagic FeversThe contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.Influenza A virus-specific CD8 T-cell responses: from induction to function.Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
P2860
Q33788131-890D493B-BFC7-4064-BFBA-BC18BB1DD599Q33911908-1FEFE7E4-56ED-4489-A005-27657011F1D0Q35826994-FD686294-78AD-404D-AC5D-1379A5D2EEDBQ36210847-4C0C2A2D-007C-4EB2-89AB-6F2CA718703FQ36315031-4EB6071B-D9C7-4891-9D3D-492BC8117D55Q36315159-F92D1146-17DE-4145-B09A-BCC31204C011Q36588064-1ECDEBE3-EB0A-47CA-BD68-13C1DE7263CDQ36612929-5D446712-5436-4F1E-A8C0-BE50E0AA0DF6Q36677419-1D6C66E7-2E1B-4D3A-B894-A4433EBC0A30Q37033291-61415447-C601-4BCE-BF0F-90774B30EEE5Q39897122-90112CD9-E74C-4FBD-8F73-30DB36C2B11AQ40074644-014FE569-D60F-4E06-955F-553286F285AFQ45399754-C30071C2-E118-42AA-B5DD-136B4B466392Q45872770-D5F2FD67-894F-4DD6-B95B-315B224F4980Q47244680-C588080B-65D8-41D2-A8BE-66DA2C543CDB
P2860
Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Induction of cytotoxic T lymph ...... indications for cross-priming.
@en
type
label
Induction of cytotoxic T lymph ...... indications for cross-priming.
@en
prefLabel
Induction of cytotoxic T lymph ...... indications for cross-priming.
@en
P2093
P50
P1433
P1476
Induction of cytotoxic T lymph ...... indications for cross-priming.
@en
P2093
Barry-Lee Waarts
Jacqueline de Vries
Laura Bungener
Marijke Holtrop
P304
P356
10.1016/J.VACCINE.2003.10.003
P407
P577
2004-03-01T00:00:00Z